Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marin

Showing results (341-350 of 453) with videos related to

Pageof 46
Sort By:
Nuclear Medicine Communications|March 19, 2020
Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancerCristina E Ueda, Paulo S Duarte, Luciana A de Castroneves, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Gene conversion is a key driver of diversity hotspots in <i>M. tuberculosis</i> antigens and virulence-associated lociMaximillian G Marin, Natalia Quinones-Olvera, Hu Jin, et al.
The Journal of Biological Chemistry|February 24, 2010
Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolitesShadi Abu-Hayyeh, Pablo Martinez-Becerra, Siti H Sheikh Abdul Kadir, et al.
International Journal of Molecular Sciences|February 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular CarcinomaSara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 11, 2017
Chemoresistance and chemosensitization in cholangiocarcinomaJose J G Marin, Elisa Lozano, Elisa Herraez, et al.
Nanotechnology, Science and Applications|May 27, 2026
Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell ModelsMartin Manov, Denitsa Stefanova, Virginia Tzankova, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 8, 2017
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinomaRocio I R Macias, Jesus M Banales, Bruno Sangro, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 29, 2011
Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acidsRaúl González, Adolfo Cruz, Gustavo Ferrín, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathwayM A Serrano, R I R Macias, M Vallejo, et al.
Biochemical Pharmacology|September 18, 2023
Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitorsElisa Herraez, Ruba Al-Abdulla, Meraris Soto, et al.
Pageof 46

Showing results (341-350 of 453) with videos related to

Sort By:
Pageof 46
Nuclear Medicine Communications|March 19, 2020
Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancerCristina E Ueda, Paulo S Duarte, Luciana A de Castroneves, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Gene conversion is a key driver of diversity hotspots in <i>M. tuberculosis</i> antigens and virulence-associated lociMaximillian G Marin, Natalia Quinones-Olvera, Hu Jin, et al.
The Journal of Biological Chemistry|February 24, 2010
Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolitesShadi Abu-Hayyeh, Pablo Martinez-Becerra, Siti H Sheikh Abdul Kadir, et al.
International Journal of Molecular Sciences|February 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular CarcinomaSara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 11, 2017
Chemoresistance and chemosensitization in cholangiocarcinomaJose J G Marin, Elisa Lozano, Elisa Herraez, et al.
Nanotechnology, Science and Applications|May 27, 2026
Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell ModelsMartin Manov, Denitsa Stefanova, Virginia Tzankova, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 8, 2017
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinomaRocio I R Macias, Jesus M Banales, Bruno Sangro, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 29, 2011
Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acidsRaúl González, Adolfo Cruz, Gustavo Ferrín, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathwayM A Serrano, R I R Macias, M Vallejo, et al.
Biochemical Pharmacology|September 18, 2023
Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitorsElisa Herraez, Ruba Al-Abdulla, Meraris Soto, et al.
Pageof 46